New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii

J Med Chem. 1995 Nov 24;38(24):4739-59. doi: 10.1021/jm00024a001.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Drug Design*
  • Humans
  • Immunosuppression Therapy
  • Molecular Structure
  • Opportunistic Infections / drug therapy*
  • Opportunistic Infections / physiopathology
  • Pneumonia, Pneumocystis / drug therapy*
  • Pneumonia, Pneumocystis / physiopathology
  • Structure-Activity Relationship